{"name":"Agomelatine","slug":"agomelatine","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Thymanax","Valdoxan","S-20098","Agomelatina","Ago-178","S 20098","N-(2-(7-methoxy-1-naphthyl)ethyl)acetamide","agomelatinum","Ago178","N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide"],"brands":[],"scraped":true,"has_structure":true,"cid":82148,"classes":[],"families":[{"name":"phenethylamine","href":"/substituted/phenethylamine"}],"physical":[{"label":"Molecular mass","value":"243.30 g/mol","copyable":false},{"label":"Solubility","value":"~0.5 mg/ml in 1:1 EtOH:PBS (pH 7.2); ~30 mg/ml in EtOH, DMF &amp; DMSO","copyable":false},{"label":"Predicted LogP","value":"2.7","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>15</sub>H<sub>17</sub>NO<sub>2</sub>","copyable":true},{"label":"IUPAC name","value":"N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide","copyable":true},{"label":"SMILES","value":"CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC","copyable":true},{"label":"InChI","value":"InChI=1S/C15H17NO2/c1-11(17)16-9-8-13-5-3-4-12-6-7-14(18-2)10-15(12)13/h3-7,10H,8-9H2,1-2H3,(H,16,17)","copyable":true},{"label":"InChIKey","value":"YJYPHIXNFHFHND-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"138112-76-2","copyable":true},{"label":"UNII","value":"137R1N49AD","copyable":true},{"label":"PubChem CID","value":"82148","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"1–2 hours","copyable":false},{"label":"Metabolism","value":"Liver (90% CYP1A2 and 10% CYP2C9)","copyable":false},{"label":"Excretion","value":"Kidney (80%, mostly as metabolites)","copyable":false},{"label":"Routes of administration","value":"By mouth","copyable":false},{"label":"Dependence liability","value":"Low<a href=\"#cite_note-3\"><sup>[3]</sup></a>","copyable":false}],"toxicity":[],"dosing":null,"salts":[],"esters":[],"chirality":"achiral","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"N","description":"Nervous system"},{"code":"N06","description":"Psychoanaleptics"},{"code":"N06A","description":"Antidepressants"},{"code":"N06AX","description":"Other antidepressants"},{"code":"N06AX22","description":""},{"code":"N06AX22","description":"Agomelatine"}],"mesh":[{"name":"Hypnotics and Sedatives","id":"M0010885"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[],"mechanism":"The novel antidepressant agent, agomelatine, behaves as an agonist at melatonin receptors (MT1 and MT2) and as an antagonist at serotonin (5-HT)(2C) receptors.","side_effects":{"drug_id":82148,"drug_name":"agomelatine","url":"https://sideeffects.embl.de/drugs/82148/pt","atc_codes":["N06AX22"],"side_effects":[{"name":"Eczema","cui":"C0013595"},{"name":"Paraesthesia","cui":"C0030554"},{"name":"Pruritus","cui":"C0033774"},{"name":"Urticaria","cui":"C0042109"},{"name":"Vision blurred","cui":"C0344232"},{"name":"Hepatitis","cui":"C0019158"},{"name":"Rash erythematous","cui":"C0234913"},{"name":"Abdominal pain","cui":"C0000737"},{"name":"Gastrointestinal pain","cui":"C0687713"},{"name":"Aggression","cui":"C0001807"},{"name":"Angioedema","cui":"C0002994"},{"name":"Anxiety","cui":"C0003467"},{"name":"Back pain","cui":"C0004604"},{"name":"Mental disorder","cui":"C0004936"},{"name":"Infection","cui":"C0009450"},{"name":"Connective tissue disorder","cui":"C0009782"},{"name":"Constipation","cui":"C0009806"},{"name":"Depression","cui":"C0011570"},{"name":"Diarrhoea","cui":"C0011991"},{"name":"Dizziness","cui":"C0012833"},{"name":"Dyspepsia","cui":"C0013395"},{"name":"Eye disorder","cui":"C0015397"},{"name":"Asthenia","cui":"C0004093"},{"name":"Fatigue","cui":"C0015672"},{"name":"Gastrointestinal disorder","cui":"C0017178"},{"name":"Hallucination","cui":"C0018524"},{"name":"Headache","cui":"C0018681"},{"name":"Hyperhidrosis","cui":"C0020458"},{"name":"Influenza","cui":"C0021400"},{"name":"Irritability","cui":"C0022107"},{"name":"Jaundice","cui":"C0022346"},{"name":"Nasopharyngitis","cui":"C0027441"},{"name":"Nausea","cui":"C0027497"},{"name":"Nervous system disorder","cui":"C0027765"},{"name":"Nightmare","cui":"C0028084"},{"name":"Restless legs syndrome","cui":"C0035258"},{"name":"Tinnitus","cui":"C0040264"},{"name":"Tremor","cui":"C0040822"},{"name":"Vertigo","cui":"C0042571"},{"name":"Vomiting","cui":"C0042963"},{"name":"Weight increased","cui":"C0043094"},{"name":"Weight decreased","cui":"C0043096"},{"name":"Dry mouth","cui":"C0043352"},{"name":"Hepatic failure","cui":"C0085605"},{"name":"Agitation","cui":"C0085631"},{"name":"Migraine","cui":"C0149931"},{"name":"Blood alkaline phosphatase increased","cui":"C0852911"},{"name":"Skin disorder","cui":"C0037274"},{"name":"Abnormal dreams","cui":"C0234458"},{"name":"Hypomania","cui":"C0241934"},{"name":"Hepatobiliary disease","cui":"C0267792"},{"name":"Mania","cui":"C0338831"},{"name":"Suicidal ideation","cui":"C0424000"},{"name":"Face oedema","cui":"C0542571"},{"name":"Infestation","cui":"C1384353"},{"name":"Insomnia","cui":"C0917801"},{"name":"Somnolence","cui":"C2830004"}],"indications":[{"name":"Major depression","cui":"C1269683"}]},"effects":null,"usernotes":[],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Australia","status":"Schedule 4","act":null,"refs":[4]},{"jurisdiction":"Brazil","status":"C1","act":null,"refs":[5]},{"jurisdiction":"United Kingdom","status":"Prescription only","act":null,"refs":[6]},{"jurisdiction":"European Union","status":"Prescription only","act":null,"refs":[7,8]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Agomelatine"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/82148"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q395229"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB06594"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL10878"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A134990"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=138112-76-2"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0015636"},{"source":"KEGG","url":"https://www.kegg.jp/entry/D02578"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID3057642"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Agomelatine"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/137R1N49AD"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/82148/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 82148, Agomelatine. Accessed November 21, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/82148>https://pubchem.ncbi.nlm.nih.gov/compound/82148</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Agomelatine. UNII: 137R1N49AD. Global Substance Registration System. Accessed November 21, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/137R1N49AD>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/137R1N49AD</a>","Kim HK, Yang KI. Melatonin and melatonergic drugs in sleep disorders. Translational and Clinical Pharmacology. December 2022; 30(4):163–171. PMID 36632077. <a href='https://doi.org/10.12793/tcp.2022.30.e21'>https://doi.org/10.12793/tcp.2022.30.e21</a>","Valdoxan Product Information. TGA eBusiness Services. 2013-09-23. <a href='https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&amp;id=CP-2010-PI-07273-3'>https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&amp;id=CP-2010-PI-07273-3</a>","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-04-04. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>","Valdoxan 25 mg film-coated tablets - Summary of Product Characteristics (SmPC). (emc). 13 July 2020. <a href='https://www.medicines.org.uk/emc/product/6564/smpc'>https://www.medicines.org.uk/emc/product/6564/smpc</a>","Thymanax EPAR. European Medicines Agency (EMA). 17 September 2018. <a href='https://www.ema.europa.eu/en/medicines/human/EPAR/thymanax'>https://www.ema.europa.eu/en/medicines/human/EPAR/thymanax</a>","Valdoxan EPAR. European Medicines Agency (EMA). 17 September 2018. <a href='https://www.ema.europa.eu/en/medicines/human/EPAR/valdoxan'>https://www.ema.europa.eu/en/medicines/human/EPAR/valdoxan</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 19:00:43","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 19:00:39","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 19:00:39","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 19:00:39","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 19:00:39","note":"hmdb.ca refused automated access to HMDB0015636"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 19:00:40","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 19:00:38","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 19:00:39","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 19:00:39","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 19:00:39","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 19:00:39","note":null}],"description":"Agomelatine is a  substance."}